Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial

INTRODUCTION: Hypertension combined with diabetes and hypokalemia is more likely to develop hyperaldosteronism and is at higher risk of cardiovascular events. There is evidence that activation of aldosterone and mineralocorticoid receptors may play a significant role in the occurrence of cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nanfang, Lin, Mengyue, Heizhati, Mulalibieke, Wang, Lin, Luo, Qin, Li, Yuanyuan, Yili, Jina, Hong, Jing, Yao, Xiaoguang, Zhu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678363/
https://www.ncbi.nlm.nih.gov/pubmed/33444188
http://dx.doi.org/10.1136/bmjopen-2020-038694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678363/
https://www.ncbi.nlm.nih.gov/pubmed/33444188
http://dx.doi.org/10.1136/bmjopen-2020-038694

Ejemplares similares